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Abstract
Background: Polymers are attractive materials for both biomedical engineering and
cardiovascular applications. Although nano-topography has been found to influence cell behaviour,
no established method exists to understand and evaluate the effects of nano-topography on
polymer-blood interaction.
Results: We optimized a micro-fluidic set-up to study the interaction of whole blood with nano-
structured polymer surfaces under flow conditions. Micro-fluidic chips were coated with
polymethylmethacrylate films and structured by polymer demixing. Surface feature size varied from
40 nm to 400 nm and feature height from 5 nm to 50 nm. Whole blood flow rate through the
micro-fluidic channels, platelet adhesion and von Willebrand factor and fibrinogen adsorption onto
the structured polymer films were investigated. Whole blood flow rate through the micro-fluidic
channels was found to decrease with increasing average surface feature size. Adhesion and
spreading of platelets from whole blood and von Willebrand factor adsorption from platelet poor
plasma were enhanced on the structured surfaces with larger feature, while fibrinogen adsorption
followed the opposite trend.
Conclusion: We investigated whole blood behaviour and plasma protein adsorption on nano-
structured polymer materials under flow conditions using a micro-fluidic set-up. We speculate that
surface nano-topography of polymer films influences primarily plasma protein adsorption, which
results in the control of platelet adhesion and thrombus formation.
Background
Blood compatibility of materials is one of the major issues
of medical engineering. Devices for cardiovascular appli-
cations are widely used but still do not exhibit optimal
performances and must be often combined with anticoag-
ulation drugs, with important implications for patient
health and therapy costs [1]. The techniques available to
evaluate the blood compatibility of materials to date are
still limited, in spite of the heavy demand for methods
allowing the quantitative and accurate characterization of
Published: 19 February 2008
Journal of Nanobiotechnology 2008, 6:3 doi:10.1186/1477-3155-6-3
Received: 12 September 2007
Accepted: 19 February 2008
This article is available from: http://www.jnanobiotechnology.com/content/6/1/3
© 2008 Minelli et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11
(page number not for citation purposes)
Journal of Nanobiotechnology 2008, 6:3 http://www.jnanobiotechnology.com/content/6/1/3the polymers used in the construction of cardiovascular
devices [2].
The difficulties encountered in characterising the interac-
tion of blood with materials are due principally to the
complexity of the phenomena involved. The adsorption
and subsequent conformational changes of proteins from
the blood are the first events that take place when blood
contacts an artificial material. Then, platelets adhere over
the adsorbed protein layer, react with it and thrombus for-
mation is eventually initiated [1,3]. Many surface modifi-
cation techniques [4,5] such as chemical treatment [6,7]
or specific molecular immobilization [8-11] have been
explored to control polymer interaction with blood cells
and proteins.
The interaction of blood with the materials' surface
involves mechanisms that occur at different length scales.
Interestingly, natural tissue surfaces such as blood vessels
exhibit features in the nanometer range and nano-topog-
raphy has been found to influence cell behaviour, includ-
ing morphology [12], adhesion [13] and motility [14] for
a number of cells [12,13,15-20], in static and flow [21]
conditions. It is still unclear though to what extent surface
topography influences blood behaviour and, therefore,
materials' blood compatibility, and what the mechanisms
involved are. To our knowledge no systematic studies
were conducted to understand the effects of nano-topog-
raphy on blood-polymer interaction. In this work we
describe a micro-fluidic set-up for investigating the inter-
action of blood with polymer nano-structured surfaces
under flow conditions and we provide some basic data on
the platelet adhesion and plasma protein adsorption on
nano-structured polymethylmethacrylate (PMMA) sur-
faces.
The study is performed by using a Micro-Channel Array
Flow Analyzer (MC-FAN, Figure 1A), which was previ-
ously utilized to characterize the interaction of whole
blood and plasma proteins with metal surfaces providing
interesting insights into the importance of surface energy
on blood coagulation mechanism [22]. Our intention is
to demonstrate that the MC-FAN is a viable in vitro set-up
for the study of the interaction of blood with a large class
of polymers and surfaces and thus for a first-stage selec-
tion of potential blood compatible materials, avoiding
the costs, the long times and the sacrifice of animals
required by in vivo experiments.
This study was approved by the Ethics Committee of
NIMS.
Results
Topographical and Chemical Characterization of the 
Surfaces
Polymer demixing is a well known technique to study the
response of cells to nano-topography [20] and was used in
this work to create a set of nano-structured polymer sur-
faces having typical feature sizes between 40 nm and 400
nm. Briefly, polymer films are spin coated from a blend of
polystyrene (PS) and PMMA. Due to their immiscibility,
the two polymers form separate phases during solvent
evaporation. The PS phase is subsequently removed by
selective solvent treatment, leaving a structured PMMA
film. The geometry of the PMMA surface structures is con-
trolled varying the experimental parameters such as poly-
mer concentration in solution and spin velocity. This
technique is fast, inexpensive and particularly suitable for
the fabrication of nano-structured films onto surfaces hav-
ing complex geometries [23] such as the micro-fluidic
The Micro-fluidic experiment set upFigure 1
The Micro-fluidic experiment set up. (A) Schematic of 
the MC-FUN set up (not to scale). (B) Top view of a micro-
fluidic chip (15 mm × 15 mm). (C) Particulars of the micro-
channels. (D) Geometrical parameters of the micro-fluidic 
chip.Page 2 of 11
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Atomic Force Microscopy (AFM) topographical image of a
PMMA film surface structured by polymer demixing is
shown in Figure 2A. The average feature size and height
were estimated from both AFM topographical and section
images of the film surfaces, and their values represent the
distance between the centre of a feature and the centre of
a valley between two features. The film thickness was
measured from AFM section profiles after having
scratched the film with Teflon tweezers. The AFM meas-
urements were performed on different areas of the same
film and on similar films; the average measured values are
shown in Table 1. Film thickness varied from 10 nm to 50
nm.
X-ray Photoelectron Spectroscopy (XPS) measurements
on samples prepared as PMMA1 (pure PMMA), PMMA2,
PMMA3, PMMA4 and on pure PS films were performed to
study the chemical composition of the films at the poly-
mer/blood interface. Figure 2B shows the typical XPS C1s
spectrum of a flat PMMA film (PMMA1). The C1s spec-
trum of pure PMMA is the result of the convolution of
four peaks: the hydrocarbon (C-C/C-H) at a binding
energy of 285.0 eV, the β-shifted carbon (due to their jux-
taposition to O-C=O groups) at 285.7 eV, the methoxy
group carbon at 286.8 eV and the carbon in the ester
group at 289.1 eV [24]. The C1s spectrum of pure PS (Fig.
2C) includes a main hydrocarbon peak at binding energy
of 285.0 eV. Figure 3D shows the typical C1s spectra of a
Characterization of the structured PMMA filmsFigure 2
Characterization of the structured PMMA films. (A) AFM topographical image of PMMA3 surface, structured using the 
polymer demixing technique. (B) XPS C1s spectrum of a surface of pure PMMA. The spectrum is the result of the convolution 
of four peaks, indicated in numbers on the PMMA molecules. (C) XPS C1s spectrum of a pure PS surface. (D) XPS C1s spectrum 
of a surface similar to PMMA3 (black line). For comparison the spectrum relative to pure PMMA is shown (dashed line), 
together with the difference between the two spectra (in gray), computed overlapping the ester peaks at 289.1 eV of the two 
spectra, that contain the contribution of the solely PMMA.Page 3 of 11
(page number not for citation purposes)
Journal of Nanobiotechnology 2008, 6:3 http://www.jnanobiotechnology.com/content/6/1/3structured PMMA surface. For comparison, the spectrum
relative to pure PMMA is also shown (dashed line). As the
ester peak at 289.1 eV contains contribution solely from
PMMA, the spectrum of pure PMMA was normalized to
the spectrum of each structured PMMA film to overlap the
peaks relative to the ester group. From this the difference
between the spectra was computed. In the case of the
PMMA3 surface, this difference is shown in grey in Figure
2D and is attributed to the presence of PS hydrocarbon
groups at or close to the surface. Computational analysis
of the XPS spectra allowed the calculation of the compo-
sition of a 10 nm-thick layer of the polymer film at the
polymer/air interface. PMMA was found to constitute (84
± 16)%, (77 ± 15)% and (71 ± 14)% of respectively sam-
ple PMMA2, PMMA3 and PMMA4 films.
Experiment performed with whole blood
Figure 3A shows the volume flow rate of a NaCl solution
(0.9% NaCl in MilliQ water) through micro-channels
coated with structured PMMA films. Error bars represent
the maximum and minimum values recorded from
repeated experiments. The volume which flows through
the channels varies linearly with time and does not depend
on the geometry of the polymer film. Figure 3B shows the
same measurements using human whole blood: in this
case the velocity of the blood flow volume decreases with
increasing surface structure size. During the blood flow
measurements, platelets were seen adhering onto the
material surfaces, aggregating and eventually obstructing
the micro-channels. This obstruction slowed down the
blood volume rate through the micro-array chip. This slow
down was used as an indicator of the quality of blood
interaction with the material. The shear stress that the
blood components experience is controlled by varying the
pressure under which the blood flows. For example, 100
μL of human whole blood under a pressure of 2.0 kPa were
measured to take (41 ± 8) s to pass through the micro-
channel array of the chip coated with a flat PMMA layer,
that signifies a shear rate of (3700 ± 700) s-1.
Optical investigation of the chip surface before and after
rinsing showed the presence of a higher density of firmly
adhered platelets on films with larger feature size. The
chip surfaces were investigated using Scanning Electron
Microscopy (SEM) after the micro-fluidic experiments and
platelet fixation. Figure 4A shows a low magnification
image of a part of the chip, where several platelets are seen
to adhere along the micro-channel walls and in the areas
around them. Closer views of the channel walls are shown
in Figures 4B, C and 4D, for the PMMA2, PMMA3 and
PMMA4 surfaces respectively. Different platelet morphol-
Table 1: PMMA film coating parameters and AFM characterization.
PMMA Sample [Polymer] in toluene (%) Feature size (nm) Feature height (nm)
1 1.0 - -
2 0.1 40 ± 15 3 ± 1
3 1.0 80 ± 20 13 ± 7
4 3.0 400 ± 200 50 ± 30
Whole blood flow rate in micro-fluidic experimentsFigur  3
Whole blood flow rate in micro-fluidic experiments. 
Volume flow rate of (A) NaCl solution and (B) whole human 
blood measured with the MC-FAN on micro-fluidic chips 
coated with PMMA films presenting different surface topog-
raphies, as reported in Table 1.Page 4 of 11
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anchor to the three polymer films. Platelets appeared
rounded on PMMA2 and 3, and more flattened and inter-
connected on the PMMA4 surface. Platelets adhered on
PMMA2 film have a smoother surface with respect to
those on PMMA3.
Experiments performed with washed platelets
100 μL of washed platelet solution was flowed through
the chip channels exhibiting different topographies. The
number of platelets that adhered onto each surface
appeared to vary depending on the surface feature size.
Figures 5A and 5B show optical images of a portion of the
chip surface of PMMA2 and PMMA4 respectively during
the blood flow and after the chip was rinsed with NaCl
solution. The dots visible on the chip surfaces are the
platelets. For the duration of the flow, the density of plate-
let adherence on PMMA4 is lower than on PMMA2. Chip
rinsing does not cause a significant detachment of the
platelets from the surface, indicating that they are firmly
adhered onto the polymer film. Quantitative investiga-
tion of platelet density was performed by SEM. Figure 5C
shows the statistical distribution of platelet adhered onto
the different topographies. Each histogram bar represents
the average number of adhered platelets calculated from
20 SEM images with the same surface area (2.99·103
μm2), while the error bars are the standard deviations of
each distribution. The average number of adhered plate-
lets per unit area decreases with increasing feature size.
However, close examination of the platelets by SEM did
not reveal any morphological difference between them in
relation to the different topographies.
Plasma Protein Adsorption Analysis
Figure 6A shows a typical SEM image of gold and silver
labelled von Willebrand factor adsorbed from platelet
poor plasma onto a PMMA structured surface. Figure 6B
shows the analysis of fibrinogen and von Willebrand fac-
tor distribution on SiO2 (reference material), PMMA1,
PMMA2, PMMA3 and PMMA4 surfaces. Each histogram
bar represents the average of the protein coverage distribu-
tion calculated from 20 SEM images having the same area
Platelet morphologyFigure 4
Platelet morphology. SEM images of platelets adhered onto topographically structured PMMA surfaces after the BPT meas-
urements. (A) Large view of the micro-channels coated with PMMA3. (B) Detail of a micro-channel coated with PMMA2, (C) 
PMMA3, (D) PMMA4.Page 5 of 11
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of the distribution. The results are normalized to the pro-
tein adsorption onto the SiO2 surface of a bare chip.
Fibrinogen adsorption onto surfaces PMMA1, PMMA2
and PMMA3 is comparable, while it is significantly
reduced on PMMA4. Von Willebrand factor adsorption is
favoured on structured PMMA surfaces with respect to flat
surfaces, and increased on surfaces with larger feature
sizes.
Discussion
We describe a micro-fluidic set-up to study human whole
blood interaction with nano-structured polymer films
and characterize it in terms of whole blood flow rate,
platelet adhesion and protein adsorption on the materi-
als. Compared with conventional techniques, this set-up
presents the notable features of requiring a reduced
amount of blood, 100 μL, for testing each material. This
offers the possibility of using this device in conjunction
Microfluidic experiments with washed plateletsFigure 5
Microfluidic experiments with washed platelets. Opti-
cal images of (A) PMMA2 and (B) PMMA4 coated chips dur-
ing the flow experiments performed with washed platelets 
(WP). The images were taken when (1) 20 μL and (2) 80 μL 
of WP solution had passed through the channels and (3) after 
chip rinsing. The arrows indicate the flow direction. (C) Sta-
tistical distribution of adhered platelets onto the chips having 
different surface topographies according to Table 1 after 
rinsing. Each bar represents the average number of platelets 
counted over 20 SEM images having the same surface area.
Plasma protein adsorption analysisFigure 6
Plasma protein adsorption analysis. (A) SEM image of 
gold and silver labelled von Willebrand factors proteins on a 
PMMA3 surface. (B) Statistical protein distribution on chips 
having different surface topographies as reported in Table 1. 
Each bar represents the average silver surface coverage eval-
uated over 20 SEM images having the same surface area. The 
data are normalized to the bare chip surface.Page 6 of 11
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ated with using animal blood, such as differences in reac-
tions between different species. Using flow conditions we
obtain an impression of the interaction of blood with
materials consistent with physiological phenomena; for
example, it has been demonstrated that translocating
platelets undergo a series of morphological changes in
response to increasing fluid shear stress [25], while the
activation of plasma proteins such as von Willebrand fac-
tors depends on the shear stress they experience [26-28].
One intrinsic limiting factor to note when comparing cell
response to micro- and nanostructures is that different
techniques are used to create structures on different scales.
The use of these different techniques means that micro-
and nanostructures can have different surface chemistries.
Using polymer demixing only it was possible to produce
a set of surfaces having feature sizes varying from the
nanometer to the sub-micrometer length scales. XPS
chemical analysis of the sample surfaces showed that
PMMA is the major (but not sole) component of the film
at the interface with blood. The presence of PS domains
embedded in the structured films is due to rapid quench-
ing of the solvent during the film spin-coating not allow-
ing the PS and PMMA phases to separate completely. The
XPS measurements will encompass the outer surface of
the film, to a depth of approximately 10 nm. However,
even here a gradient of PS concentration should occur, as
the cyclohexane treatment will leach PS from the last few
nm of the surface. We are therefore confident that chemi-
cal variation between the sample surfaces will be reduced
and the major differences in responses to the films can be
attributed to surface topography.
Blood flow rate measurements and SEM investigation of
platelet morphology concur and indicate that blood inter-
acts differently with the polymer films depending on
topography. Data indicates that surfaces with smaller fea-
tures are potentially less thrombogenic. We can identify
three main factors that can influence blood interaction
with structured surfaces: 1) different topographies may
alter the flow dynamic; 2) different topographies may
influence the platelet anchoring and adhesion behaviour
onto the polymer surfaces; 3) different topographies may
cause dissimilar protein adsorption behaviours.
Surface roughness is found to influence flow dynamics
through micro-channels [29,30]; however, numerical
simulations indicate that the effects produced are negligi-
ble for the geometry of our set up, characterized by Rey-
nolds number < 1 and height of the surface structures
relative to the channel height < 0.02.
Platelet anchoring and adhesion behaviour onto the pol-
ymer surfaces were studied using both whole blood and
washed platelets, i.e. in the absence of blood cells and
plasma proteins. Using washed platelets allows the level
of activation of the platelets induced by sample handling
to be assessed. It is possible that this was sufficient to ini-
tiate their adhesion onto the surfaces in absence of the
plasma proteins. In the case of experiments performed
with whole blood the platelets were seen to adhere and
spread preferentially on the polymer films with larger sur-
face feature size.
Conversely, washed platelet adhesion was reduced onto
surfaces having larger feature sizes and height of the struc-
tures. Optical investigation of the chip surface during
micro-fluidic experiments excluded the possibility that
lower platelet density on the chip surfaces could be due to
the formation of large platelet clusters loosely adhered
onto the surface and thus easily removed during the rins-
ing procedure. We conclude that isolated platelets
adhered preferentially on surfaces with smaller feature
size. This result, together with the fact that no morpholog-
ical differences were observed between the washed plate-
lets adhered onto the different topographies, suggests a
significant role of the plasma proteins, as well as the
blood cells, in the platelet activation mechanism. During
experiments performed with whole blood, the erythro-
cytes and leucocytes may apply a mechanical force to the
platelets close to the channel walls when passing through,
encouraging their adhesion and activation.
A key protein for regulation dynamic platelet responses is
von Willebrand factor. Under shear stress, platelets roll
through blood vessels and across surfaces. Platelet rolling
is slowed by the formation and breaking of successive
translocating bonds with von Willebrand factors. Eventu-
ally, if the platelet has slowed enough, stronger bonds
form and the platelet firmly anchors to the surface
[31,32]. Therefore, surfaces exhibiting a high level of
adsorbed von Willebrand factor are more likely to favour
platelet adhesion and consequent thrombus formation.
Interestingly, lower flow rates were measured for the sur-
faces exhibiting the higher level of von Willebrand factor
absorption. This is particularly interesting, as smaller fea-
ture sizes will give a larger surface area, and might intui-
tively be thought to result in more protein binding.
Fibrinogen is a rod-like protein with an important role in
thrombogenesis. Our results indicate that fibrinogen
adsorption is favoured on surfaces having typical feature
size of ~100 nm, while those having larger feature sizes
exhibit lower levels of adsorbed fibrinogen.
The two protein we analyzed exhibited opposing adsorp-
tion trends with respect to the total surface area of the
chips, eliminating this as the sole effect on protein adsorp-
tion behaviour on structured surfaces. The reasons why
protein adsorption behaviour varies between feature sizePage 7 of 11
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might have significantly contributed to protein displace-
ment and further investigation is required. It has been
shown that the supermolecular organization of proteins
can be controlled both by surface chemistry and by sur-
face nano-topography [34]. Roach et al[35] showed that
proteins of different shapes can associate with a surface in
quite dissimilar ways and that surface curvature has an
effect on the protein-surface binding affinity and packing
density. Their findings suggest that the surface nano-
topography may influence both conformation and inter-
molecular organization of the adsorbed proteins. These
effects would be enhanced in the case of rod-like proteins
such as the von Willebrand factor and the fibrinogen,
both having dimension comparable with the size of the
surface features (the von Willebrand factor is estimated
about 120 nm in length, while fibrinogen was measured
to be about 47 nm × 4 nm [36]). Further investigation is
however necessary for elucidating how proteins interact
with surface nano-topography under flow condition.
Conclusion
In conclusion, we have presented a set up for the study of
blood interaction with topographically structured poly-
mer surfaces under flow conditions. We demonstrated the
utility of this device for measuring the blood flow rate
through micro-channels coated with nano-structured
PMMA films and we related these values to platelet adhe-
sion and protein adsorption analysis performed on the
same surfaces. The results of our investigation indicate
that platelet adhesion and consequent thrombus forma-
tion is increased onto nano-structured polymer films pre-
senting typical feature sizes of ~400 nm. Interestingly
these are the surfaces that present a higher level of von
Willebrand factor adsorption. Platelets adhered on such
films were found to be flattened and interconnected. No
difference in platelet morphology on the various topogra-
phies could be observed when platelets were isolated from
plasma proteins and blood cells. The fact that adhesion
behaviour of washed platelets differed from those in
whole blood suggests the significant roles of blood cells
and plasma protein adsorption in the activation of
adhered platelet in our system. Plasma protein adsorption
on nano-structured polymer surfaces was also studied
under flow conditions and different adsorption behav-
iours were found for fibrinogen and von Willebrand fac-
tor. We speculate that both the size and the shape of the
proteins may have a major role in determining the way
these proteins interact with the structured materials.
Methods
Nano-structured surfaces preparation
Micro-channel array chips made of silicon (model
Bloody6–7, Hitachi Haramachi Electronics Co. Ltd.,
Japan) with a 20 nm thick silicon oxide layer at the inter-
face with air were used. The 8736 micro-channels of each
chip were 30 μm-long and presented a wedge-shaped
cross-section, 4.5 μm-deep and between 5 μm and 10 μm-
wide. The micro-fluidic chips were coated by spin coating
with a polymer film structured by polymer demixing
[37,38]. PS (Mw = 108700, n = 1.06, Polymer Source, Can-
ada) and PMMA (Mw = 190000, n = 1.8, Polymer Source,
Canada) were diluted in toluene at 3.0%, 1.0% and 0.1%
(w/v) concentration and stored at room temperature over-
night. Polymer blends were made by mixing equal vol-
ume portions of stock solutions of each polymer. Polymer
films were made by spin coating polymer blends onto the
silicon chips at 6000 rpm for 60 s each. The chips were
then incubated in cyclohexane for 10 minutes and soni-
cated for 1 minute to remove the PS molecules from the
film surface. The chips were stored in MilliQ H2O over-
night and sonicated in a 0.9% NaCl solution in MilliQ
H2O for 1 minute before each micro-fluidic experiment.
Samples prepared with the same protocol were dried
under a nitrogen flux and characterized by AFM (SPI4000
E-Sweep, Seiko Instruments Inc., Japan) and XPS (Quan-
tum 2000, Physical Electronics, MN, USA). XPS measure-
ments were also performed on a pure PS film for
reference. The XPS data were analyzed with the software
MultiPak V6.1A (Physical Electronics, Inc.). XPS data
analysis and elaboration allowed the estimate that the
information contained in each spectrum relate to the out-
ermost 10 nm-thick layer of the polymer film.
Blood collection
Blood was collected from a healthy individual after
informed consent. Heparin was added to a final concen-
tration of 5 IU/mL for the experiments performed with
whole blood, which were executed within 30 minutes
after blood collection. 1 mL of the collected blood was
mixed with 1% (w/v) ethylenediaminetetracetic acid dis-
odium salt (EDTA, Dojindo Laboratories, Japan) in Mil-
liQ H2O and analyzed with a particle counter (PCE-170,
Erma Inc., Japan) for blood cell counts. The average
number of platelets in the whole blood measured was
(2.6 ± 0.3)·105/μL.
Washed platelet solution and platelet poor plasma were
prepared by centrifuging a 9 : 1 solution of whole blood
and 1% EDTA in MilliQ H2O in two stages. First the solu-
tion was centrifuged at 180 g and the platelet rich plasma
was collected. This was then centrifuged at 600 g to sepa-
rate the platelets from the platelet poor plasma. The col-
lected platelets were gently redispersed in HEPES solution
– 140 mM NaCl, 5 mM KCl, 5 mM D-glucose (Wako Pure
Chemical Industries, Japan) and 10 nM hidroxyethyl-
piperazine-ethanosulfonic acid (Research Organics, OH,
USA) in MilliQ H2O – to a final concentration of 8.9·104/μL. CaCl2 (final conc. 0.1 mM) was added just before the
measurements.Page 8 of 11
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The micro-fluidic chip was set upside down into the flow
chamber of the MC-FAN (KH-3; Hitachi Haramachi Elec-
tronics Co. Ltd., Japan) in order to form an array of micro-
channels at the boundary with the chamber glass window.
For each sample, 100 μL of blood was poured in the cen-
tral hole of the flow chamber. A tube filled with 0.9%
NaCl solution connected the central hole to a volume
flow sensor, which was connected to a stopwatch. Another
tube connected the flow chamber to a waste bottle, placed
20 cm below the flow volume sensor. The waste bottle was
also connected to a pump. When the valve of the pump
was opened to air, the blood flowed through the micro-
channel array under a pressure difference of 20 cm H2O
(2.0 kPa) and the blood flow rate was measured by the
stopwatch. Simultaneously, the channels were observed
by an optical microscope equipped with a CCD camera
(LCL-211H, Watec Co. Ltd., Japan) and recorded on a PC.
The flow chamber was held by an XY-stage equipped with
micrometric screws to observe different chip areas with
the camera. After the blood flow, the chip surface was vis-
ually investigated and typically some platelets were seen
to be adhered to the material's surface. The micro-fluidic
chamber was also connected to a bottle of 0.9% NaCl
solution used to wash the micro-channels under a 53 kPa
pressure to qualitatively evaluate the strength of this adhe-
sion.
The pass-through time of a 0.9% NaCl solution in MilliQ
H2O was measured before every blood test to evaluate the
channel volume variation due to the chip fabrication
process and the thickness of the coated polymer film. The
presented data were corrected for this effect. Blood coagu-
lation was monitored measuring the blood flow rate on a
reference material (bare silicon) before every measure-
ment on a coated chip in order to select consistent results
for the data analysis.
Micro-fluidic measurements with washed platelet
The vertical distance between the MC-FAN volume flow
sensor and the waste bottle was set to 10 cm (1.0 kPa), in
order to keep shear conditions similar to those experi-
ments performed with the whole blood (We assume
blood viscosity 4.4 mPas and washed platelet viscosity
similar to that of plasma 1.9 mPas. In separate experi-
ments with the MC-FAN we verified the linearity of the
relationship between the flow rate, pressure and inverse of
the viscosity). The same measurement protocol described
for whole blood was adopted for the micro-fluidic exper-
iment with WP.
Platelet fixation
After the micro-fluidic measurements, the chips were
removed from the flow chamber and washed three times
in 1% Dulbecco's Phosphate Buffered Saline without cal-
cium and magnesium (PBS, Nissui Pharmaceutical Co.
Ltd., Japan) shaking to remove the loosely adhered cells
and platelets. The chips were then stored at 4°C in a 1%
gluteraldehyde (Electron Microscopy Science, PA, USA) in
H2O solution for four hours, rinsed with MilliQ H2O,
dehydrated via successive incubations in H2O/ethanol
mixtures with increasing ethanol content and stored at
4°C. The samples were gold coated before investigation
by Scanning Electron Microscopy (SEM, S-4800, Hitachi,
Japan).
Plasma protein adsorption analysis
For experiments with platelet poor plasma the vertical dis-
tance between the MC-FAN volume flow sensor and the
waste bottle was set to 10 cm. The platelet poor plasma
was allowed to flow through the chip channels for 1 min.
The chips were then rinsed in PBS and stored overnight in
a blocking solution – 5% (v/v) Milk Diluent/Blocking
Solution Concentrate (KPL, MD, USA) with 2 mM EDTA
in MilliQ H2O which is filtered by a 0.2 μm membrane fil-
ter – at 4°C. The next day, each chip was cut into two
parts, and fibrinogen and von Willebrand factor from
platelet poor plasma were labelled with gold nanoparti-
cles for SEM analysis; the size of the gold labels and thus
their visibility in SEM was enhanced by silver treatment as
described in the next section. The chips were finally rinsed
with MilliQ H2O and dehydrated via successive incuba-
tions in H2O/ethanol mixtures with increasing ethanol
content. The PMMA films exhibited several metal aggrega-
tions at their surfaces under SEM investigation. For each
micro-fluidic chip we took 20 SEM micrographs from dif-
ferent areas and we counted the number of proteins
present at the surface, associating each aggregation with
one single adsorbed protein.
Von Willebrand factor and fibrinogen gold labeling
The labelling protocol comprises three main parts: after
rinsing in PBS solution, the chip pieces are incubated in 2
μg/mL of primary antibodies for each protein in 1% (w/v)
Ovalbumine solution (INC Biomedicals Inc., OH, USA)
for 60 minutes at 37°C. The chips are then stored in a
0.1% gluteraldehyde in H2O solution for 30 minutes at
4°C. The chips are incubated for 45 minutes at 37°C in a
10 nm gold labelled secondary antibody solution pre-
pared as suggested by the manufacturer (BBI interna-
tional, Cardiff, UK). Fibrinogens were labelled with anti-
human fibrinogen IgG developed in goat (Sigma, MO,
USA) as primary antibody and gold labelled Rabbit anti-
Goat IgG as secondary antibody. Von Willebrand factors
were labelled using anti-human von Willebrand factor
IgG developed in rabbit (Sigma, MO, USA) as primary
antibody, and 10 nm gold labelled Goat anti-Rabbit IgG
as secondary antibody. The chips are rinsed in MilliQ H2O
and stored overnight in 1% gluteraldehyde in H2O solu-
tion. The next day, a silver enhancer procedure (SilverPage 9 of 11
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to increase the size of the gold labels and thus their visi-
bility in SEM observation. The final particle size was
below 100 nm.
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